Dentsply Sirona (XRAY) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $8.57, -2.94% vs the prior close of $8.83.
- Volume 4.18M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XRAY dips 2.9% to $8.57. Closed at $8.57, -2.94% vs the prior close of $8.83. Day range $8.54–$8.93, opened at $8.89.
XRAY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — XRAY dips 2.9% to $8.57
- Closed at $8.57, -2.94% vs the prior close of $8.83. Day range $8.54–$8.93, opened at $8.89.
- Volume was 4.18M shares, 0.9x its 50-day average of 4.59M.
- Price is -15.4% vs its 50-day average ($10.13) and -25.3% vs its 200-day average ($11.47).
- 52-week range $8.32–$14.76; today's close sits at 4% of that range, 41.9% below the 52-week high.
Oct 15, 2026 — XRAY jumps 4.6% to $8.83
- Closed at $8.83, +4.62% vs the prior close of $8.44. Day range $8.32–$8.86, opened at $8.49.
- Volume was 5.18M shares, 1.1x its 50-day average of 4.56M.
- Price is -13.6% vs its 50-day average ($10.22) and -23.1% vs its 200-day average ($11.49).
- 52-week range $8.32–$14.76; today's close sits at 8% of that range, 40.2% below the 52-week high.
Oct 14, 2026 — XRAY dips 0.8% to $8.44, a 52-week low, 3 down days in a row
- Closed at $8.44, -0.82% vs the prior close of $8.51. Day range $8.33–$8.58, opened at $8.42.
- Volume was 3.97M shares, 0.9x its 50-day average of 4.57M.
- Price is -18.2% vs its 50-day average ($10.32) and -26.6% vs its 200-day average ($11.50).
- 52-week range $8.33–$14.76; today's close sits at 2% of that range, 42.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — XRAY ends flat (-0.2%) to $8.51, a 52-week low
- Closed at $8.51, -0.23% vs the prior close of $8.53. Day range $8.42–$8.70, opened at $8.58.
- Volume was 3.94M shares, 0.9x its 50-day average of 4.63M.
- Price is -18.5% vs its 50-day average ($10.44) and -26.1% vs its 200-day average ($11.52).
- 52-week range $8.38–$14.76; today's close sits at 2% of that range, 42.3% below the 52-week high.
Oct 12, 2026 — XRAY slides 3.4% to $8.53
- Closed at $8.53, -3.40% vs the prior close of $8.83. Day range $8.49–$8.94, opened at $8.75.
- Volume was 4.69M shares, 1.0x its 50-day average of 4.61M.
- Price is -19.2% vs its 50-day average ($10.55) and -26.0% vs its 200-day average ($11.53).
- 52-week range $8.38–$14.76; today's close sits at 2% of that range, 42.2% below the 52-week high.
Oct 9, 2026 — XRAY rises 1.6% to $8.83, 3 up days in a row
- Closed at $8.83, +1.61% vs the prior close of $8.69. Day range $8.56–$8.87, opened at $8.70.
- Volume was 4.22M shares, 0.9x its 50-day average of 4.60M.
- Price is -17.1% vs its 50-day average ($10.65) and -23.5% vs its 200-day average ($11.54).
- 52-week range $8.38–$14.76; today's close sits at 7% of that range, 40.2% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — XRAY rises 1.8% to $8.69
- Closed at $8.69, +1.76% vs the prior close of $8.54. Day range $8.42–$8.70, opened at $8.43.
- Volume was 6.20M shares, 1.4x its 50-day average of 4.59M.
- Price is -19.1% vs its 50-day average ($10.75) and -24.8% vs its 200-day average ($11.55).
- 52-week range $8.38–$14.76; today's close sits at 5% of that range, 41.1% below the 52-week high.
Oct 7, 2026 — XRAY ends flat (+0.2%) to $8.54
- Closed at $8.54, +0.23% vs the prior close of $8.52. Day range $8.38–$8.55, opened at $8.46.
- Volume was 4.22M shares, 0.9x its 50-day average of 4.60M.
- Price is -21.3% vs its 50-day average ($10.86) and -26.2% vs its 200-day average ($11.57).
- 52-week range $8.38–$14.76; today's close sits at 3% of that range, 42.1% below the 52-week high.
Oct 6, 2026 — XRAY dips 0.5% to $8.52, a 52-week low, 10 down days in a row
- Closed at $8.52, -0.47% vs the prior close of $8.56. Day range $8.47–$8.69, opened at $8.58.
- Volume was 4.71M shares, 1.0x its 50-day average of 4.59M.
- Price is -22.2% vs its 50-day average ($10.96) and -26.4% vs its 200-day average ($11.58).
- 52-week range $8.44–$14.76; today's close sits at 1% of that range, 42.3% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 — XRAY dips 1.3% to $8.56, a 52-week low, 9 down days in a row
- Closed at $8.56, -1.27% vs the prior close of $8.67. Day range $8.44–$8.70, opened at $8.55.
- Volume was 5.01M shares, 1.1x its 50-day average of 4.57M.
- Price is -22.5% vs its 50-day average ($11.05) and -26.2% vs its 200-day average ($11.60).
- 52-week range $8.44–$14.76; today's close sits at 2% of that range, 42.0% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — XRAY dips 0.8% to $8.67, a 52-week low, 8 down days in a row
- Closed at $8.67, -0.80% vs the prior close of $8.74. Day range $8.59–$8.85, opened at $8.74.
- Volume was 5.79M shares, 1.3x its 50-day average of 4.61M.
- Price is -22.1% vs its 50-day average ($11.13) and -25.3% vs its 200-day average ($11.61).
- 52-week range $8.59–$14.76; today's close sits at 1% of that range, 41.3% below the 52-week high.
- That makes 8 straight losses.
XRAY latest news & SEC filings
Every SEC filing by or about XRAY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $898.00M (prior year $936.00M) (-4.1% vs Jun 30, 2025)
- Net income: $37.00M (prior year -$45.00M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.18 (prior year -$0.22) (swung to profit vs Jun 30, 2025)
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Exhibits / financial statements only (Item 9.01).
Jul 21, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade XRAY
- Last results release: May 5, 2026 (8-K Item 2.02). Previous ones: Feb 26, 2026, Nov 6, 2025, Aug 7, 2025. Based on that rhythm, the next report is likely around Aug 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.87% (largest 5.4%).
- Liquidity: about 4.93M shares (≈$42.26M) trade per day on average.
- 52-week position: $8.57 vs a range of $8.32–$14.76 (4% of the range).
- Dividends: last ex-dividend date Dec 26, 2025 ($0.16/share); 1 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Clyde Hosein bought 6,500 shares on Jun 15, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K Jun 11, 2026.
- Share count: 199.35M shares outstanding (Jul 24, 2026), -0.1% vs a year earlier.
- Listing: Nasdaq · industry: Dental Equipment & Supplies.
XRAY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.89 | 8.93 | 8.54 | 8.57 | 4.18M |
| Oct 15, 2026 | 8.49 | 8.86 | 8.32 | 8.83 | 5.18M |
| Oct 14, 2026 | 8.42 | 8.58 | 8.33 | 8.44 | 3.97M |
| Oct 13, 2026 | 8.58 | 8.70 | 8.42 | 8.51 | 3.94M |
| Oct 12, 2026 | 8.75 | 8.94 | 8.49 | 8.53 | 4.69M |
| Oct 9, 2026 | 8.70 | 8.87 | 8.56 | 8.83 | 4.22M |
| Oct 8, 2026 | 8.43 | 8.70 | 8.42 | 8.69 | 6.20M |
| Oct 7, 2026 | 8.46 | 8.55 | 8.38 | 8.54 | 4.22M |
| Oct 6, 2026 | 8.58 | 8.69 | 8.47 | 8.52 | 4.71M |
| Oct 5, 2026 | 8.55 | 8.70 | 8.44 | 8.56 | 5.01M |
| Oct 2, 2026 | 8.74 | 8.85 | 8.59 | 8.67 | 5.79M |
| Oct 1, 2026 | 8.85 | 8.90 | 8.61 | 8.74 | 5.94M |
| Sep 30, 2026 | 9.08 | 9.12 | 8.83 | 8.86 | 6.55M |
| Sep 29, 2026 | 9.21 | 9.29 | 8.91 | 8.98 | 4.60M |
| Sep 28, 2026 | 9.32 | 9.32 | 8.90 | 9.28 | 5.68M |
| Sep 25, 2026 | 9.52 | 9.63 | 9.29 | 9.40 | 4.89M |
| Sep 24, 2026 | 9.76 | 9.81 | 9.48 | 9.53 | 3.74M |
| Sep 23, 2026 | 9.89 | 10.00 | 9.74 | 9.78 | 3.35M |
| Sep 22, 2026 | 9.66 | 10.02 | 9.65 | 9.95 | 5.13M |
| Sep 21, 2026 | 9.57 | 9.64 | 9.41 | 9.44 | 6.65M |
About Dentsply Sirona
Dentsply Sirona (XRAY) is listed on the Nasdaq and classified by the SEC under “Dental Equipment & Supplies”. Its business address is in CHARLOTTE, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 818479.
XRAY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael J Barber | Director | Jun 15, 2026 |
| Willie A Deese | Director | Jan 13, 2026 |
| James D Forbes | Director | Jun 5, 2026 |
| Brian T Gladden | Director | Jun 15, 2026 |
| Betsy D Holden | Director | Jun 15, 2026 |
| Clyde Hosein | Director | Jun 16, 2026 |
| Gregory T Lucier | Director | Jun 5, 2026 |
| Jonathan Jay Mazelsky | Director | Jul 1, 2026 |
| Brian P Mckeon | Director | Jun 15, 2026 |
| Daniel T Scavilla | President, CEO & Member of BOD | May 26, 2026 |
| Leslie F Varon | Director | Jun 5, 2026 |
| Janet S. Vergis | Director | Jun 5, 2026 |
| Donald Zurbay | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lindi Rene Barton-Brobst | SVP, GC & Secretary | Jun 18, 2026 |
| Kevin Czerney | VP, Chief Accounting Officer | Mar 12, 2026 |
| Aldo Mariano Roberto Denti | EVP, Chief Commercial Officer | Mar 12, 2026 |
| John C. Fortson | EVP & CFO | Aug 12, 2026 |
| Andrea L. Frohning | SVP, CHRO | Aug 11, 2026 |
| Matthew E Garth | EVP & CFO | Oct 15, 2025 |
| Robert Anthony Johnson | SVP, Chief Supply Chain Office | Mar 6, 2026 |
| Richard C Rosenzweig | EVP, Corp Dev, GC & Secretary | Oct 15, 2025 |
| Daniel T Scavilla | President, CEO & Member of BOD | May 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 15, 2026 | Clyde Hosein | Buy | 6,500 | $9.99 |
| Jun 15, 2026 | Clyde Hosein | Buy | 6,500 | $9.99 |
| Jun 15, 2026 | Clyde Hosein | Buy | 6,500 | $9.99 |
| Jun 15, 2026 | Clyde Hosein | Buy | 6,500 | $9.99 |
| Jun 15, 2026 | Brian T Gladden | Buy | 9,985 | $10.02 |
| Jun 15, 2026 | Brian T Gladden | Buy | 9,985 | $10.02 |
| Jun 15, 2026 | Brian T Gladden | Buy | 9,985 | $10.02 |
| Jun 15, 2026 | Brian T Gladden | Buy | 9,985 | $10.02 |
| Jun 12, 2026 | Jonathan Jay Mazelsky | Buy | 10,000 | $10.14 |
| Jun 12, 2026 | Jonathan Jay Mazelsky | Buy | 10,000 | $10.14 |
| Jun 12, 2026 | Jonathan Jay Mazelsky | Buy | 10,000 | $10.14 |
| Jun 12, 2026 | Jonathan Jay Mazelsky | Buy | 10,000 | $10.14 |
| Jun 12, 2026 | Brian P Mckeon | Buy | 10,000 | $10.12 |
| Jun 12, 2026 | Brian P Mckeon | Buy | 10,000 | $10.12 |
| Jun 12, 2026 | Brian P Mckeon | Buy | 10,000 | $10.12 |
XRAY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.68B | $-598.00M | -3.00 | $235.00M |
| Dec 31, 2024 | $3.79B | $-910.00M | -4.48 | $461.00M |
| Dec 31, 2023 | $3.96B | $-132.00M | -0.62 | $377.00M |
| Dec 31, 2022 | $3.92B | $-950.00M | -4.41 | $517.00M |
| Dec 31, 2021 | $4.23B | $411.00M | 1.87 | $657.00M |
Latest balance sheet: total assets $5.20B, total liabilities $3.85B, cash $239.00M (as of Jun 30, 2026).
XRAY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 5, 2026 | 8-K Item 2.02 (results) | $11.37 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $12.71 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $11.02 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $13.23 |
| Jul 21, 2025 | 8-K Item 2.02 (results) | $15.63 |
| May 8, 2025 | 8-K Item 2.02 (results) | $15.91 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $17.15 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $17.26 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $24.41 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Dental Equipment & Supplies
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XRAY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.